208 related articles for article (PubMed ID: 15831498)
1. The balance between acetylation and deacetylation controls Smad7 stability.
Simonsson M; Heldin CH; Ericsson J; Grönroos E
J Biol Chem; 2005 Jun; 280(23):21797-803. PubMed ID: 15831498
[TBL] [Abstract][Full Text] [Related]
2. Control of Smad7 stability by competition between acetylation and ubiquitination.
Grönroos E; Hellman U; Heldin CH; Ericsson J
Mol Cell; 2002 Sep; 10(3):483-93. PubMed ID: 12408818
[TBL] [Abstract][Full Text] [Related]
3. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
[TBL] [Abstract][Full Text] [Related]
4. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling.
Bai S; Cao X
J Biol Chem; 2002 Feb; 277(6):4176-82. PubMed ID: 11711531
[TBL] [Abstract][Full Text] [Related]
5. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
[TBL] [Abstract][Full Text] [Related]
6. The deacetylase HDAC1 negatively regulates the cardiovascular transcription factor Krüppel-like factor 5 through direct interaction.
Matsumura T; Suzuki T; Aizawa K; Munemasa Y; Muto S; Horikoshi M; Nagai R
J Biol Chem; 2005 Apr; 280(13):12123-9. PubMed ID: 15668237
[TBL] [Abstract][Full Text] [Related]
7. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.
Lallemand F; Seo SR; Ferrand N; Pessah M; L'Hoste S; Rawadi G; Roman-Roman S; Camonis J; Atfi A
J Biol Chem; 2005 Jul; 280(30):27645-53. PubMed ID: 15946939
[TBL] [Abstract][Full Text] [Related]
8. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts.
Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K
J Clin Invest; 2004 Jan; 113(2):253-64. PubMed ID: 14722617
[TBL] [Abstract][Full Text] [Related]
9. AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.
Yamaguchi Y; Kurokawa M; Imai Y; Izutsu K; Asai T; Ichikawa M; Yamamoto G; Nitta E; Yamagata T; Sasaki K; Mitani K; Ogawa S; Chiba S; Hirai H
J Biol Chem; 2004 Apr; 279(15):15630-8. PubMed ID: 14752096
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation.
Kume S; Haneda M; Kanasaki K; Sugimoto T; Araki S; Isshiki K; Isono M; Uzu T; Guarente L; Kashiwagi A; Koya D
J Biol Chem; 2007 Jan; 282(1):151-8. PubMed ID: 17098745
[TBL] [Abstract][Full Text] [Related]
11. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane.
Suzuki C; Murakami G; Fukuchi M; Shimanuki T; Shikauchi Y; Imamura T; Miyazono K
J Biol Chem; 2002 Oct; 277(42):39919-25. PubMed ID: 12151385
[TBL] [Abstract][Full Text] [Related]
12. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation.
Pulaski L; Landström M; Heldin CH; Souchelnytskyi S
J Biol Chem; 2001 Apr; 276(17):14344-9. PubMed ID: 11278814
[TBL] [Abstract][Full Text] [Related]
14. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
[TBL] [Abstract][Full Text] [Related]
15. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.
Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I
J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425
[TBL] [Abstract][Full Text] [Related]
17. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of prothymosin-α antagonizes TGFβ signalling to promote the development of emphysema.
Su BH; Tseng YL; Shieh GS; Chen YC; Wu P; Shiau AL; Wu CL
J Pathol; 2016 Feb; 238(3):412-22. PubMed ID: 26496995
[TBL] [Abstract][Full Text] [Related]
19. Differential ubiquitination defines the functional status of the tumor suppressor Smad4.
Morén A; Hellman U; Inada Y; Imamura T; Heldin CH; Moustakas A
J Biol Chem; 2003 Aug; 278(35):33571-82. PubMed ID: 12794086
[TBL] [Abstract][Full Text] [Related]
20. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]